Cargando…

Loss of Toll-like receptor 7 alters cytokine production and protects against experimental cerebral malaria

BACKGROUND: Malaria, caused by Plasmodium sp. parasites, is a leading cause of global morbidity and mortality. Cerebral malaria, characterized by neurological symptoms, is a life-threatening complication of malaria affecting over 500,000 young children in Africa every year. Because of the prevalence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baccarella, Alyssa, Huang, Brian W, Fontana, Mary F, Kim, Charles C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164820/ https://www.ncbi.nlm.nih.gov/pubmed/25192715 http://dx.doi.org/10.1186/1475-2875-13-354

Ejemplares similares

Toll-like receptor polymorphisms and cerebral malaria: TLR2 Δ22 polymorphism is associated with protection from cerebral malaria in a case control study
por: Greene, Jennifer A, et al.
Publicado: (2012)

Toll-like receptor 2-mediated downstream cytokine levels as determinant of malaria pathogenesis
por: Kalita, Manash Pratim, et al.
Publicado: (2023)

Association of Cytokine and Toll-Like Receptor Gene Polymorphisms with Severe Malaria in Three Regions of Cameroon
por: Apinjoh, Tobias O., et al.
Publicado: (2013)

Glucagon-like peptide-1 analogue, liraglutide, in experimental cerebral malaria: implications for the role of oxidative stress in cerebral malaria
por: DellaValle, Brian, et al.
Publicado: (2016)

FCRL5(+) Memory B Cells Exhibit Robust Recall Responses
por: Kim, Charles C., et al.
Publicado: (2019)

Erratum to: Glucagon-like peptide-1 analogue, liraglutide, in experimental cerebral malaria: implications for the role of oxidative stress in cerebral malaria
por: DellaValle, Brian, et al.
Publicado: (2016)

Concurrent gastro-intestinal nematode infection does not alter the development of experimental cerebral malaria
por: de Souza, Brian, et al.
Publicado: (2008)

The Toll for Trafficking: Toll-Like Receptor 7 Delivery to the Endosome
por: Petes, Carlene, et al.
Publicado: (2017)

Cytokines and Chemokines in Cerebral Malaria Pathogenesis
por: Dunst, Josefine, et al.
Publicado: (2017)

Trimming of sequence reads alters RNA-Seq gene expression estimates
por: Williams, Claire R., et al.
Publicado: (2016)

Downstream Toll-like receptor signaling mediates adaptor-specific cytokine expression following focal cerebral ischemia
por: Famakin, Bolanle, et al.
Publicado: (2012)

Toll-like receptor polymorphisms in malaria-endemic populations
por: Greene, Jennifer A, et al.
Publicado: (2009)

Toll Like receptor 7 regulates viral loads and cytokine secretion during acute retroviral infection
por: Browne, E
Publicado: (2012)

Protective Role of Toll-like Receptor 4 in Experimental Gonococcal Infection of Female Mice
por: Packiam, Mathanraj, et al.
Publicado: (2011)

Toll-like receptors in cerebral ischemic inflammatory injury
por: Wang, Yan-Chun, et al.
Publicado: (2011)

Treatment Reducing Endothelial Activation Protects against Experimental Cerebral Malaria
por: Mota, Sabrina, et al.
Publicado: (2022)

Role of Cytokines and Toll-Like Receptors in the Immunopathogenesis of Guillain-Barré Syndrome
por: Nyati, Kishan Kumar, et al.
Publicado: (2014)

KCC1 Activation protects Mice from the Development of Experimental Cerebral Malaria
por: Hortle, Elinor, et al.
Publicado: (2019)

BCG Provides Short-Term Protection from Experimental Cerebral Malaria in Mice
por: Witschkowski, Julia, et al.
Publicado: (2020)

α-Synuclein Alters Toll-Like Receptor Expression
por: Béraud, Dawn, et al.
Publicado: (2011)

The protective effect of the anti-Toll-like receptor 9 antibody against acute cytokine storm caused by immunostimulatory DNA
por: Murakami, Yusuke, et al.
Publicado: (2017)

Toll-like Receptor 4 Signaling Pathway in the Protective Effect of Pioglitazone on Experimental Immunoglobulin A Nephropathy
por: Zou, Jia-Nan, et al.
Publicado: (2017)

Placental Toll-Like Receptor 3 and Toll-Like Receptor 7/8 Activation Contributes to Preeclampsia in Humans and Mice
por: Chatterjee, Piyali, et al.
Publicado: (2012)

Microglia Activation in Retinal Ischemia Triggers Cytokine and Toll-Like Receptor Response
por: Wagner, Natalie, et al.
Publicado: (2020)

Potential Medications or Compounds Acting on Toll-like Receptors in Cerebral Ischemia
por: Li, Man, et al.
Publicado: (2018)

The Early Induction of Suppressor of Cytokine Signaling 1 and the Downregulation of Toll-like Receptors 7 and 9 Induce Tolerance in Costimulated Macrophages
por: Lee, Hyo-Ji, et al.
Publicado: (2015)

Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients
por: Mantovani, Stefania, et al.
Publicado: (2021)

Altered Toll-Like Receptor Signalling in Children with Down Syndrome
por: Huggard, Dean, et al.
Publicado: (2019)

TAK-242, an antagonist for Toll-like receptor 4, protects against acute cerebral ischemia/reperfusion injury in mice
por: Hua, Fang, et al.
Publicado: (2015)

Cytokines and Adhesion Molecules Expression in the Brain in Human Cerebral Malaria
por: Armah, Henry, et al.
Publicado: (2005)

INHIBITION OF TOLL-LIKE RECEPTOR 4 PROTECTS AGAINST INFLAMMATION-INDUCED MECHANOBIOLOGICAL ALTERATIONS TO INTERVERTEBRAL DISC CELLS
por: Jacobsen, T.D., et al.
Publicado: (2021)

Association of toll-like receptors in malaria susceptibility and immunopathogenesis: A meta-analysis
por: Ramirez Ramirez, Aína Danaisa, et al.
Publicado: (2022)

BNT162b2 COVID-19 vaccination in children alters cytokine responses to heterologous pathogens and Toll-like receptor agonists
por: Noé, Andrés, et al.
Publicado: (2023)

Anti-tumor Activity of Toll-Like Receptor 7 Agonists
por: Chi, Huju, et al.
Publicado: (2017)

Dissecting the role of toll‐like receptor 7 in pancreatic cancer
por: Stark, Maren, et al.
Publicado: (2023)

Toll-like receptor 7 deficiency protects apolipoprotein E-deficient mice from diet-induced atherosclerosis
por: Liu, Cong-Lin, et al.
Publicado: (2017)

The Imidazoquinoline Toll-Like Receptor-7/8 Agonist Hybrid-2 Potently Induces Cytokine Production by Human Newborn and Adult Leukocytes
por: Ganapathi, Lakshmi, et al.
Publicado: (2015)

Protection from experimental cerebral malaria with a single intravenous or subcutaneous whole-parasite immunization
por: Heiss, Kirsten, et al.
Publicado: (2018)

Author Correction: KCC1 Activation protects Mice from the Development of Experimental Cerebral Malaria
por: Hortle, Elinor, et al.
Publicado: (2020)

Age-Dependent Maturation of Toll-Like Receptor-Mediated Cytokine Responses in Gambian Infants
por: Burl, Sarah, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_h90t3u48balhghlghslqvp5p5a